Phase II-IV Clinical Trial Management
-
At Micro Data Labs, we excel in supporting Phase II-IV clinical studies for investigational new drugs (INDs), biologics, and medical devices. Backed by the team with over 20 years of experience in clinical operations, we provide a robust framework and a full suite of services to manage the complexities of multi-center clinical trials across diverse therapeutic areas. Our comprehensive offerings cover the entire trial lifecycle, including study feasibility assessments, pre-site qualifications, study initiation, patient recruitment, site management, and detailed monitoring through Central, Remote, and on-site methods.
30+
Late Phase Studies
Late Phase Studies
5000+
Patients
Patients
Discover Our Services
140+
Sites
Sites
Micro Data Labs has successfully enrolled over 5,000+ patients conducting end to end clinical trials, across a wide range of therapeutic areas and conducted more than 30+ multi-center trials across various regions. We have submitted data to leading regulatory agencies, including the US FDA, EMEA, DCGI, and ANVISA, through both standalone trials and collaborative efforts.